Objective: To evaluate the effects of addition of human milk (HM) fortifier and iron on the anti-infective properties of HM.
Introduction
Anti-infective properties of human milk (HM) are well known. This is especially important for the premature baby, who has a relative immunodeficiency and who stay in the neonatal intensive care unit for a prolonged time. Those babies who receive HM show a decrease in the rate of infections. 1 However, as the nutritional properties of HM are insufficient to meet the requirements of premature babies, fortification of HM is considered often. Although there are many HM fortifiers on the market, only one brand is available in our country. We sought whether the addition of this HM fortifier to HM decreased the anti-infective properties of HM or not.
Study design
Using a sterile breast pump, HM samples were collected from 30 lactating mothers who delivered prematurely, within the first week of post-natal life. All of the mothers were healthy and were not on any medication except vitamins. The mean gestational age was 33.4 weeks. On each occasion at least 30 ml HM was obtained and transferred to sterile containers and kept at À201C until laboratory investigation. At the time of investigation, milk samples were thawed under tap water. Each sample was divided into three aliquots. The first aliquot contained pure HM, the second aliquot contained HM fortified with Eoprotin according to the recommendations of the manufacturer (1 g per 30 ml milk) and the the third aliquot contained milk supplemented with ferrous sulfate drops at a concentration of 0.38 mg elemental iron per 30 ml milk. The contents of Eoprotin are seen in Table 1 .
Anti-infective properties of each aliquot were evaluated by bacterial inhibition and bacterial growth methods. Bacterial inhibition was evaluated by using the filter paper method. A disk of filter paper was soaked with the milk and placed on the surface of 5% sheep blood agar plate previously inoculated with either Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa or Candida albicans all of which were obtained commercially. The inhibition zone around the disk was measured 24 to 36 h later.
In order to analyze bacterial growth, 1 ml of milk sample was mixed with 1 ml bacterial suspension, containing 10 5 to 10 7 colonies and incubated at 371C for 3.5 h. Later, these suspensions were plated on 5 % blood agar plates and incubated at 371C for 24 h and a colony count was performed at the end. The study was approved by the Ethical Committee of the Institution and written informed consent was obtained from all lactating mothers for the purpose of the study.
Analysis of variance was used to compare means among milk groups. P<0.05 was considered statistically significant.
Results
HM inhibited the growth of E. coli, S. aureus, P. aeruginosa and Candida. The addition of HM fortifier did not change this effect and the inhibitor zones were similar to those of pure HM. However, addition of iron resulted in a significant difference in the antimicrobial effect of HM against E. coli, S. aureus and P. aeruginosa but not Candida. These results are seen in Table 2 . Results of bacterial growth are seen in Table 3 .
Discussion
This study clearly showed that HM inhibits the growth of E. coli, S. aureus, P. aeruginosa and C. albicans. As these microorganisms are responsible for the majority of infections in newborns, the effect of using HM for the prevention of infections especially in premature babies becomes evident. HM exerts an antimicrobial effect not only on bacteria, but on many viruses and fungi also.
2 This is clinically reflected in the lower incidence of bacterial, viral and fungal infections such as septicemia, meningitis, pneumonia and necrotizing enterocolitis in babies who are exclusively breast-fed. Other studies also support these findings. 3 In some studies, the rate of infections have been found to have increased in babies who receive fortified HM. 4 The main reason of this increase is the nature of the HM fortifier used. Some fortifiers contain medium-chain fatty acids and iron, which decrease the antimicrobial efficacy of HM. 5 On the other hand, there are some studies which conclude that addition of HM fortifier containing various amounts of iron does not decrease the antimicrobial properties of HM. 6, 7 However, these studies were intended to test the storage conditions of HM and they were performed either at room temperature or in the refrigerator, conditions which themselves may preclude the growth of bacteria. In our study, the incubations were carried out at 371C mimicking the body temperature and after the addition of iron to HM, the antimicrobial efficacy decreased almost to zero, making a significant difference. As the HM fortifier available in our country contains trace amounts of fatty acids and no iron, it does not change the antimicrobial effect of HM. The effect of Eoprotin on the antimicrobial activity of HM was demonstrated by bacterial inhibition power and by bacterial colony counts, which did not change after fortifications.
The main iron-binding element in HM is lactoferrin. Lactoferrin binds iron which is required by bacteria for their optimal growth. 8, 9 The addition of iron saturates lactoferrin, which results in decreased antimicrobial effect. In fact, lactoferrin binds only ferric iron. However, even if ferrous iron is used, this is quickly converted to ferric iron in the body and binds to lactoferrin. On the other hand, premature babies have increased iron needs and iron supplementation is carried out almost in every neonatal unit. Owing to its interactions with lactoferrin, it may be prudent to give supplemental iron cautiously.
Conclusion
Premature HM has strong antimicrobial properties and HM fortifier available in our country, namely Eoprotin does not inhibit this efficacy. Addition of iron, on the other hand, decreases this property and therefore, if needed, iron supplementation should be given separate from HM feedings. Human milk fortifier and infection
